Asunto(s)
Adulto , Niño , Femenino , Humanos , Masculino , Corazón Fetal/cirugía , Cardiopatías Congénitas/cirugía , Insuficiencia Cardíaca/cirugía , Trasplante de Corazón/métodos , Trasplante de Corazón/normas , Brasil , Feto , Cardiopatías Congénitas/diagnóstico , Insuficiencia Cardíaca/congénito , Insuficiencia Cardíaca/diagnóstico , Medición de Riesgo , Factores de Riesgo , Sociedades MédicasAsunto(s)
Corazón Fetal/cirugía , Cardiopatías Congénitas/cirugía , Insuficiencia Cardíaca/cirugía , Trasplante de Corazón/métodos , Trasplante de Corazón/normas , Adulto , Brasil , Niño , Femenino , Feto , Cardiopatías Congénitas/diagnóstico , Insuficiencia Cardíaca/congénito , Insuficiencia Cardíaca/diagnóstico , Humanos , Masculino , Medición de Riesgo , Factores de Riesgo , Sociedades MédicasRESUMEN
O artigo não apresenta resumo.
RESUMEN
O artigo não apresenta resumo.
RESUMEN
Hemoglobinopathies are associated with thrombotic complications, when exposed to cardiopulmonary bypass. A 54-year old, black woman with hemoglobinopathy SC and severe mitral stenosis was submitted to eritrocytopheresis 48 hours before mitral commissurotomy surgery. The therapeutic determined appearance of the percentual hemoglobin A of 68% with reduction the hemoglobin S of 48% to 15% and the hemoglobin C of 51% to 17%. No complications occurred during postoperative period. To best of our knowledge, that is the first report about application the eritrocytopheresis in the pre operative extra corporeal circulation care in surgical treatment of patients with chronic rheumatic heart disease and hemoglobinopathy SC.